Catherine Saï-Maurel

²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Michel Chérel, Sébastien Gouard, Joëlle Gaschet et al. · Journal of Nuclear Medicine · 2013 · 77 citations · Full text

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

Caroline Rousseau, A. Ruellan, Karine Bernardeau et al. · EJNMMI Research · 2011 · 52 citations · Full text

Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.

Jean François Gestin, Anthony Loussouarn, Manuel Bardiès et al. · PubMed · 2001 · 44 citations

Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

Françoise Kraeber‐Bodéré, Catherine Saï-Maurel, L. Campion et al. · PubMed · 2002 · 40 citations

Experimental Mtc, Immunology, Pathology +17

Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.

Françoise Kraeber‐Bodéré, A Faibre-Chauvet, Catherine Saï-Maurel et al. · PubMed · 1999 · 40 citations